PortfoliosLab logoPortfoliosLab logo

Looking to diversify beyond CURE? The ETFs below have historically moved differently from CURE, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.

Best Diversifiers for CURE

1510 ETFs have low correlation with CURE (below 0.3), 116 of which are negatively correlated. The least correlated is United States Brent Oil Fund LP (BNO) (Oil & Gas) with a 1Y correlation of -0.31, down from -0.08 over 5 years.

How candidates are selected

SymbolNameCorrelation 1YCorrelation 3YCorrelation 5YRisk / Return RankCategoryCompare
United States Brent Oil Fund LP-0.31-0.20-0.08
52
Oil & GasCURE vs BNO
Invesco DB Energy Fund-0.30-0.20-0.06
72
Oil & GasCURE vs DBE
United States Gasoline Fund LP-0.30-0.16-0.05
87
Oil & GasCURE vs UGA
United States Oil Fund LP-0.29-0.19-0.07
55
Oil & GasCURE vs USO
Invesco DB Oil Fund-0.29-0.19-0.06
58
Oil & GasCURE vs DBO
See all 2241 diversifiers for CURE

To view more results, upgrade your current subscription plan.

Low-Correlation Stock Ideas

The table shows companies with at least $1B in market capitalization, historical correlation data for CURE, and a Risk / Return Rank of 50 or higher. Treat them as research candidates rather than evidence that they will offset a future decline. The least correlated is Murphy USA Inc. (MUSA) (Consumer Cyclical) with a 1Y correlation of 0.08, down from 0.26 over 5 years.

How candidates are selected

SymbolNameCorrelation 1YCorrelation 3YCorrelation 5YRisk / Return RankSector
Murphy USA Inc.0.080.180.26
89
Consumer Cyclical
argenx SE0.300.340.37
69
Healthcare
Realty Income Corporation0.350.390.44
77
Real Estate

Rows per page

1–3 of 3

Diversification Analysis

Build a portfolio that complements CURE

Add CURE to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with CURE